In this context, other studies such as Medina et al. interestingly showed that MSCs from patients with mantle cell lymphoma protect the malignant cells from spontaneous and drug-induced apoptosis through the secretion of B-cell activating factor and activation of the canonical and non-canonical NFκB pathways [27]. Here, TNFSF13B is linked to mantle cell lymphoma.